PubMed چکیده/رکورد

Anatomy consistent segmentation network for joint PET/CT tumor segmentation.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

Joint PET/CT imaging combines functional and anatomical information, making multimodal tumor segmentation essential in clinical oncology. However, segmentation performance is often hindered by inter-modal feature entanglement and the lack of reliable uncertainty estimates. To tackle these issues, we propose an Anatomy-Consistent Segmentation Network (ACSN) based on feature disentanglement. In this network, the multimodal inputs are first processed with a dual-branch adversarial Feature Disentanglement Module (FDM) to extract the shared anatomical features of PET and CT. These features are then fed into a Feature Fusion Module (FFM) to extract tumor-specific representations via two Multi-receptive field Segmentation Backbones (MSB) (for CT and PET, respectively) and to extract fused features (from PET and CT) based on their uncertainties. In each MSB, a Feature Space Adjustment (FSA) module is developed to better align anatomical and tumor-related features. To better fuse multi-modal features and to mitigate the mis-calibration risk of traditional uncertainty calibration approaches, a Layer-wise Uncertainty Calibrator (LUC) is developed to progressively calibrate multi-scale features across the network, enabling finer-grained modeling of epistemic uncertainty and guiding more reliable multimodal fusion. The final tumor prediction is trustworthily produced by integrating calibrated evidence from PET, CT, and their fused representation under the guidance of Dempster-Shafer theory (DST). Experiments on the AutoPET and Hecktor datasets show that ACSN achieves competitive segmentation performance under the adopted 2D axial slice-wise evaluation protocol and provides calibrated uncertainty estimates that are associated with segmentation errors. These results suggest that ACSN may provide auxiliary information for uncertainty-aware PET/CT tumor segmentation and quality control. Our code will be available at https://github.com/narutodd/ACSN.

متن کامل اصلی

متن در JumpToDate ذخیره نشده است.

برای بررسی دسترسی کتابخانه‌ای یا خرید، رکورد اصلی را باز کنید.

رفتن به منبع اصلی

کلیدواژه‌ها

Dempster-Shafer theoryDisentangled representation learningMultimodal fusion networkPET/CTTumor segmentation
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Comprehensive Approach to Prostate Cancer Metastasis Mimics at Prostate-Specific Membrane Antigen PET/CT.

Prostate-specific membrane antigen (PSMA) PET has transformed prostate cancer (PCa) imaging. Nevertheless, major diagnostic pitfalls remain as PSMA expression is not exclusive to PCa and may also occur in physiologic tissues and a range of benign and malignant conditions. These conditions may mimic PCa metastases, leading to potential misinterpretation. Accurate risk assessment of suspected lesions using PSMA PET/CT requires the integr…

PubMed2026

Preoperative porta hepatis-to-hepatic surface ratio on 24-h delayed hepatobiliary scintigraphy is associated with jaundice clearance after Kasai portoenterostomy.

PURPOSE: Biliary atresia (BA) often requires liver transplantation despite Kasai portoenterostomy (KPE). The prognostic role of hepatobiliary scintigraphy remains unclear. METHODS: Twenty-three infants undergoing KPE between 2017 and 2024 were retrospectively analyzed. Patients without 6-h bowel activity on technetium-99 m PMT hepatobiliary scintigraphy underwent 24-h delayed imaging. The primary endpoint was jaundice clearance (total …

PubMed2026

Cost-effectiveness of ferumoxtran-enhanced macrophage-specific-MRI and PSMA-PET/CT versus ePLND for nodal staging in primary prostate cancer: a decision analysis based on updated phase-3 trial data.

BACKGROUND AND OBJECTIVE: Accurate nodal staging in intermediate- to high-risk prostate cancer (PCa) is crucial for treatment decisions. While extended pelvic lymph node dissection (ePLND) is the standard, it is invasive and has a low diagnostic yield. A 2019 analysis suggested that non-invasive imaging such as PSMA-PET/CT and ferumoxtran-enhanced macrophage-MRI (m-MRI) is cost-effective, but at the possible expense of a small QALY los…

PubMed2026

Dual Dopaminergic and Limbic-Cognitive Contributions to Gait Parameters in De Novo Parkinson Disease.

BACKGROUND AND OBJECTIVES: Parkinson disease (PD) is a progressive neurodegenerative disease in which gait impairment is a common and disabling clinical feature. We aimed to characterize the independent and mediated contributions of striatal dopamine transporter (DAT) availability and gray matter (GM) volume to quantitative gait impairment in de novo PD. METHODS: In this prospective study, we consecutively recruited patients with de no…